Paola Sinibaldi

Prof. Paola Sinibaldi


Research Focus & Metrics

Academic Career Length

48Years (1979-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2005 in Oncogene
Verified
Journal Article
Closed access
ISIlaria Sciamanna
Ilaria Sciamanna
MLMatteo Landriscina
Matteo Landriscina
CPCarmine Pittoggi
Carmine Pittoggi
MQMichela Quirino
Michela Quirino
CMCristina Mearelli
Cristina Mearelli
CSCorrado Spadafora
Corrado Spadafora

1 March 2009 in Experimental Cell Research
Verified
Journal Article
Closed access
ASAnnalucia Serafino
Annalucia Serafino
EBE. Balestrieri
E. Balestrieri
PPP. Pierimarchi
P. Pierimarchi
Claudia MatteucciClaudia Matteucci
Claudia Matteucci
GMG. Moroni
G. Moroni
PSPaola Sinibaldi
Paola Sinibaldi

1 January 2008 in BMC Immunology
Verified
Journal Article
Open access
PDF file
ASAnnalucia Serafino
Annalucia Serafino
PSPaola Sinibaldi
Paola Sinibaldi
FAFederica Andreola
Federica Andreola
MZManuela Zonfrillo
Manuela Zonfrillo
LMLuana Mercuri
Luana Mercuri
PPPasquale Pierimarchi
Pasquale Pierimarchi
Besides few data concerning the antiseptic properties against a range of microbial agents and the anti-inflammatory potential both in vitro and in vivo, little is known about the influence of Eucalyptus oil (EO) extract on the monocytic/macrophagic system, one of the primary cellular effectors of the immune response against pathogen attacks. The activities of this natural extract have mainly been recognized through clinical experience, but there have been relatively little scientific studies on its biological actions. Here we investigated whether EO extract is able to affect the phagocytic ability of human monocyte derived macrophages (MDMs) in vitro and of rat peripheral blood monocytes/granulocytes in vivo in absence or in presence of immuno-suppression induced by the chemotherapeutic agent 5-fluorouracil (5-FU).

1 June 1999 in Biomedical Microdevices
Verified
Journal Article
Closed access
PDF file
TDTejal A. Desai
Tejal A. Desai
WCWen Hwa Chu
Wen Hwa Chu
GRGuido Rasi
Guido Rasi
PSPaola Sinibaldi
Paola Sinibaldi
EGEnrico Guarino
Enrico Guarino
MFMauro Ferrari
Mauro Ferrari

26 January 2017 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
AAAyele Argaw-Denboba
Ayele Argaw-Denboba
EBEmanuela Balestrieri
Emanuela Balestrieri
ASAnnalucia Serafino
Annalucia Serafino
CCChiara Cipriani
Chiara Cipriani
IBIlaria Bucci
Ilaria Bucci
Claudia MatteucciClaudia Matteucci
Claudia Matteucci
Melanoma is a heterogeneous tumor in which phenotype-switching and CD133 marker have been associated with metastasis promotion and chemotherapy resistance. CD133 positive (CD133+) subpopulation has also been suggested as putative cancer stem cell (CSC) of melanoma tumor. Human endogenous retrovirus type K (HERV-K) has been described to be aberrantly activated during melanoma progression and implicated in the etiopathogenesis of disease. Earlier, we reported that stress-induced HERV-K activation promotes cell malignant transformation and reduces the immunogenicity of melanoma cells. Herein, we investigated the correlation between HERV-K and the CD133+ melanoma cells during microenvironmental modifications. TVM-A12 cell line, isolated in our laboratory from a primary human melanoma lesion, and other commercial melanoma cell lines (G-361, WM-115, WM-266-4 and A375) were grown and maintained in the standard and stem cell media. RNA interference, Real-time PCR, flow cytometry analysis, self-renewal and migration/invasion assays were performed to characterize cell behavior and HERV-K expression. Melanoma cells, exposed to stem cell media, undergo phenotype-switching and expansion of CD133+ melanoma cells, concomitantly promoted by HERV-K activation. Notably, the sorted CD133+ subpopulation showed stemness features, characterized by higher self-renewal ability, embryonic genes expression, migration and invasion capacities compared to the parental cell line. RNA interference-mediated downregulation experiments showed that HERV-K has a decisive role to expand and maintain the CD133+ melanoma subpopulation during microenvironmental modifications. Similarly, non nucleoside reverse transcriptase inhibitors (NNRTIs) efavirenz and nevirapine were effective to restrain the activation of HERV-K in melanoma cells, to antagonize CD133+ subpopulation expansion and to induce selective high level apoptosis in CD133+ cells. HERV-K activation promotes melanoma cells phenotype-switching and is strictly required to expand and maintain the CD133+ melanoma cells with stemness features in response to microenvironmental modifications.

1 January 2015 in BioMed Research International
Verified
Journal Article
Open access
PDF file
EBEmanuela Balestrieri
Emanuela Balestrieri
FPFrancesca Pica
Francesca Pica
Claudia MatteucciClaudia Matteucci
Claudia Matteucci
RZRossella Zenobi
Rossella Zenobi
RSRoberta Sorrentino
Roberta Sorrentino
PSPaola Sinibaldi
Paola Sinibaldi
Human endogenous retroviruses (HERVs) have been implicated in human physiology and in human pathology. A better knowledge of the retroviral transcriptional activity in the general population and during the life span would greatly help the debate on its pathologic potential. The transcriptional activity of four HERV families (H, K, W, and E) was assessed, by qualitative and quantitative PCR, in PBMCs from 261 individuals aged from 1 to 80 years. Our results show that HERV-H, HERV-K, and HERV-W, but not HERV-E, are transcriptionally active in the test population already in the early childhood. In addition, the transcriptional levels of HERV-H, HERV-K, and HERV-W change significantly during the life span, albeit with distinct patterns. Our results, reinforce the hypothesis of a physiological correlation between HERVs activity and the different stages of life in humans. Studies aiming at identifying the factors, which are responsible for these changes during the individual’s life, are still needed. Although the observed phenomena are presumably subjected to great variability, the basal transcriptional activity of each individual, also depending on the different ages of life, must be carefully considered in all the studies involving HERVs as causative agents of disease.